Chime Biologics inks over $190m

Chime Biologics, a China-based provider of outsourcing services for biopharmaceutical development and manufacturing, has raised over $190 million in funding.

Chime Biologics, a China-based provider of outsourcing services for biopharmaceutical development and manufacturing, has raised over $190 million in funding. The lead investor was VMS Group.

Source: Press Release